Showing results for "One by One" in Hygiene & Healthy Living

Call it "Zen and the Art of Farming" or a "Little Green Book", Masanobu Fukuoka's manifesto about farming, eating, and the limits of human knowledge presents a radical challenge to the global systems we rely on for our food. At the same time, it is a spiritual memoir of a man whose innovative system of cultivating the earth reflects a deep faith in the wholeness and balance of the natural world. As Wendell Berry writes in his preface, the book "is valuable to us because it is at once practical and philosophical."

What will it take to run a marathon in less than two hours? The world's fastest times for the marathon have been dropping since the distance of 26.2 miles was made official nearly one hundred years ago. But after a noticeable decline that occurred for a half century, the times, while still edging lower, have stalled several minutes north of two hours for the past decade. For the first time, 1:59 examines what it will take for an elite distance runner to go subtwo hours.

Discover how GLP-1 drugs like semaglutide are revolutionizing kidney disease treatment, cutting risk by 24% in landmark trials. Join host Julia Cartwright as she uncovers the science, breakthrough research, and future of kidney protection for millions with chronic kidney disease. For more content like this, visit QuietPlease.ai

Discover how GLP-1 drugs like Ozempic and Wegovy might do far more than trim waistlines—they could slow aging itself by quieting chronic inflammation. Dr. Ben Synth unpacks the molecular science, clinical trials, and provocative evidence linking these medications to longevity, disease prevention, and biological age reversal. For more content like this, visit QuietPlease.ai

Host Julia Cartwright explores how GLP-1 drugs are emerging as a potential game-changer for women with polycystic ovary syndrome, a condition where insulin resistance, weight gain, and hormonal imbalance fuel each other in a relentless cycle. Each episode examines how these medications may help break that cycle and restore metabolic and reproductive health. For more content like this, visit QuietPlease.ai

Helping midlife women 40 – 60 lose weight and transform their health naturally and sustainably. Sharing the strategies and lessons I learned losing 100+ pounds in my mid 40s (perimenopause). For decades, I struggled with my weight and did the quick fixes, shakes, tracking apps, strict programs, and fad diets. Some of them worked… until they didn’t! In midlife, I decided I was DONE. Done with feeling crap, done with low confidence, done with restrictive quick fix diets! And then, things changed! I share real life tools for nutrition, fitness, sleep, stress management, motivation and ...

Hosted by best-selling Elsevier authors, Dr. Raj Dasgupta and Dr. Ted O'Connell, this show is designed to deliver quick USMLE review questions to help students study on the go.

Oral GLP-1 medications promise weight-loss results without needles, but can a daily pill with minimal absorption truly rival the proven power of weekly injections? Host Julia Cartwright unpacks the science, compares real-world trade-offs, and explores how new pricing models could finally make these drugs accessible to millions. For more content like this, visit QuietPlease.ai

Host Clare Delish investigates the new wave of 'GLP-1 Friendly' food labels hitting grocery store shelves, examining whether Big Food is offering genuine guidance or capitalizing on a pharmaceutical gold rush. Each episode blends sharp marketing critique with evidence-based nutrition advice for anyone trying to eat smarter—on these drugs or not. For more content like this, visit QuietPlease.ai

Clare Delish pits GLP-1 drugs against ketogenic diets in a no-nonsense breakdown of how each method works, what the science actually shows, and the side effects hiding in the fine print. Expect biology, skepticism, and real talk about trade-offs before you pick a side in the weight loss wars. For more content like this, visit QuietPlease.ai

Dr. Ben Synth unpacks the SURMOUNT-5 trial results comparing tirzepatide and semaglutide head-to-head in the largest obesity drug study ever conducted. Discover what 751 patients taught us about weight loss efficacy, cardiovascular benefits, and real-world tolerability differences that are reshaping clinical practice. For more content like this, visit QuietPlease.ai

Welcome to your source for the hottest in erotic fiction and bedtime fantasy. Our podcast features 100% original sex stories from a variety of authors. Our manager Hannah accepts quality erotic story submissions from amateur authors and holds story contests for contributors. We offer a huge selection of adult fantasies to choose from, and are always on the lookout for new and exciting ideas. We encourage you to contact us with any comments or suggestions on how we can make this sexy sleep story collection more pleasurable for you. Have fun and enjoy yourselves at intimateaudiostories.com

Discover how tirzepatide became the first FDA-approved drug for obstructive sleep apnea, offering hope to millions struggling with CPAP machines. Julia Cartwright investigates the science, patient experiences, and clinical implications of this breakthrough treatment that goes far beyond simple weight loss. For more content like this, visit QuietPlease.ai

GLP-1 drugs like Ozempic trigger dramatic weight loss, but up to 40% may be muscle, not fat. Dr. Ben Synth unpacks the hidden metabolic cost, science-backed preservation strategies, and breakthrough therapies that could revolutionize how we lose weight without losing strength. For more content like this, visit QuietPlease.ai

Host Julia Cartwright explores how GLP-1 weight loss drugs are revolutionizing obstructive sleep apnea treatment, following tirzepatide's groundbreaking FDA approval. From clinical trial results to biological mechanisms and access barriers, this series examines whether these drugs offer real hope beyond the CPAP machine for millions of Americans. For more content like this, visit QuietPlease.ai

Host Julia Cartwright explores why GLP-1 medications have surged among women navigating perimenopause and menopause. Each episode unpacks clinical trial data, safety concerns, and surprising benefits beyond weight loss—from hormone interactions to metabolic changes—helping women over 40 make evidence-based decisions about these drugs. For more content like this, visit QuietPlease.ai

Explore the groundbreaking science behind GLP-1 drugs and addiction with Dr. Ben Synth. From shared brain reward pathways to landmark veteran studies, discover how medications for diabetes and weight loss may revolutionize treatment for alcohol, opioid, nicotine, and gambling addiction. Evidence-based insights into psychiatry's most promising frontier. For more content like this, visit QuietPlease.ai

Discover the science behind GLP-1 drugs like Ozempic, Wegovy, and Mounjaro with Dr. Ben Synth. Understand how these medications work at the molecular level, why they're so effective for weight loss and diabetes, and what the expanding research means for conditions from heart disease to Alzheimer's. For more content like this, visit QuietPlease.ai

These programs constitute the core practice curriculum of mindfulness-based stress reduction (MBSR) in the Stress Reduction Clinic. They are meant to be used in conjunction with Dr. Kabat-Zinn's book, Full Catastrophe Living: Using the Wisdom of Your Body and Mind to Face Stress, Pain and Illness. You will find extensive descriptions of these practices in this book.

GLP-1 medications like Ozempic can trigger significant weight loss, but up to 39% may come from muscle, not fat. Maverick Ryder reveals why resistance training and strategic nutrition are essential to protect your metabolic health, preserve strength, and maintain results long after the shot ends. For more content like this, visit QuietPlease.ai